申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20210253554A1
公开(公告)日:2021-08-19
Compounds having the following formula I:
or a stereoisomer or pharmaceutically-acceptable salt thereof, where R
1
, R
2
, R
3
, R
4
, and R
5
are as defined herein, are useful in the modulation of IL-12, IL-23 and/or IFNα, by acting on Tyk-2 to cause signal transduction inhibition.